Success Stories: NAILG Helps a Chinese Clinical Genomics Scientist in Clinical Genetics acquire her NIW Approval without RFE
Client’s Testimonial:
“Thanks for the great news!”
On January 5th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Clinical Genomics Scientist in the Field of Clinical Genetics (Approval Notice).
General Field: Clinical Genetics
Position at the Time of Case Filing: Clinical Genomics Scientist
Country of Origin: China
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: January 5th, 2022
Processing Time: 7 months, 11 days
Case Summary:
A client, a clinical genomics scientist approached NAILG to help her obtain her NIW (National Interest Waiver) petition approval. Hailing from China, she has completed her M.S in Genetic Counseling. As an expert in the field of clinical genetics, her work related to revealing the genetic mechanisms responsible for undiagnosed genetic disorders and molecular drivers of cancer has great substantial merit and national importance. Therefore, to make a powerful case in her favor, we included the following details in her petition packet:
- Her work has resulted in 7 peer-reviewed journal articles, published in no fewer than 4 highly ranked peer-reviewed journals.
- Her publications have been cited a total of 100 times according to Google Scholar.
- She has received 2 recommendation letters from her fellow experts in the field.
Moreover, North America Immigration Law Group has also developed the most up-to-date winning strategies for the NIW category, which enable us to offer our “Approval or Refund” services to many of the NIW cases we take. However, there are certain prerequisites to be fulfilled by an individual including:
- The foreign national must be in a position to advance the proposed endeavor.
- The applicant must present evidence that the U.S. would benefit on balance to waive the job offer criteria for an EB-2.
- A proposed endeavor, holding substantial merit and national importance.